PubRank
Search
About
Nivolumab Plus Ipilimumab to Treat First Line Stage IV Non-Small Cell Lung Cancer (CheckMate568)
Clinical Trial ID NCT02659059
PubWeight™ 0.79
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT02659059
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Recent Advances in Immunotherapy in Metastatic NSCLC.
Front Oncol
2016
0.79
Next 100